Live Quote · NASDAQPROCHealthcare· Drug Manufacturers - Specialty & Generic

Procaps Group S.A.

$1.01 100.00%(+$1.01)
TickerSpark Score
65/100
Solid
100
Valuation
95
Profitability
70
Growth
32
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PROC research report →

52-Week Range16% of range
Low
$0.50
Current
$1.01
High
$3.77
Company Overviewwww.procapsgroup.com

About the company

Procaps Group S. A. , established in Luxembourg in 1977, functions as a global pharmaceutical enterprise dedicated to the creation, production, and distribution of a broad spectrum of pharmaceutical solutions.

CEO
Jose Antonio Toledo Vieira
IPO
2019
Employees
5,500
HQ
Luxembourg City, LU

Price Chart

-63.93% · this period
$3.69$2.11$0.53Apr 03Oct 08Mar 09
Valuation
Market Cap
$102.08M
P/E
2.40
P/S
0.25
P/B
-108.52
EV/EBITDA
3.62
Div Yield
0.00%
Profitability
Gross Margin
58.44%
Op Margin
12.76%
Net Margin
10.38%
ROE
-221.90%
ROIC
12.09%
Growth & Income
Revenue
$409.92M · 0.04%
Net Income
$42.54M · 142.18%
EPS
$0.42 · 140.78%
Op Income
$52.32M
FCF YoY
-236.71%
Performance & Tape
52W High
$3.77
52W Low
$0.50
50D MA
$1.94
200D MA
$2.07
Beta
0.17
Avg Volume
114.30K

Get TickerSpark's AI analysis on PROC

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Mar 18, 26Palacios Luis Albertoother0
Mar 18, 26Eguiguren Albertoother0
Mar 18, 26Garcia Iragorri Carlosother0
Mar 18, 26Bernal Jaramillo Daniel Augustoother0
Mar 18, 26Moreira Muniz Fernando Sebastianother0
Apr 9, 25Moreira Muniz Fernando Sebastianother19,800,411
Mar 18, 26Vial Claro Manuel Joseother0
Mar 18, 26Romero Camacho Carlosother0
Mar 18, 26Manieu Alexandre Weinsteinother0
Apr 9, 25Manieu Alexandre Weinsteinother79,201,647
Coverage · PROC

Our PROC coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on PROC yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate PROC report →
Internal Compare

Similar companies

Peers in the same neighborhood.